An alternative view of homocysteine

Lancet

Volumn 354, Issue 9195, 1999, Pages 2072-2074

  Dudman, Nicholas P B ^a  

^a Univ N   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

CARDIOVASCULAR RISK; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOTHESIS; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; STROKE; TISSUE INJURY; VASCULAR DISEASE;

EID: 0033547641     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03383-8     Document Type: Note

References (27)

1. Refsum H., Ueland P.M., Nygard O., Vollset S.E. Homocysteine and cardiovascular disease. Annu Rev Med. 49:1998;31-62.
2. Gudnason V., Stansbie D., Scott J., Bowron A., Nicaud V., Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentrations in different European populations (EARS group). Atherosclerosis. 136:1998;347-354.
3. Tosetto A., Missiaglia E., Frezzato M., Rodhegiero F. The VITA project: C677T mutation in the methylenetetrahydrofolate reductase gene and risk of venous thromboembolism. Br J Haematol. 97:1997;804-806.
4. Wilcken D.E.L., Wang X.L., Sim A.S., McCredie R.M. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol. 16:1998;878-882.
5. Mann N.J., Dudman N.P.B., Guo X.W., Li D., Sinclair A.J. The effect of the diet on homocysteine in healthy male subjects. Neth J Med. 52:1998;10. (suppl).
6. Egerton W., Silberberg J.S., Crooks R., Ray C., Xie L., Dudman N.P.B. Plasma levels of homocyst(e)ine during the acute phase response. Am J Cardiol. 77:1996;759-761.
7. Lindgren A., Brattstrom L.E., Norrving B., Hultberg B., Andersson A., Johansson B.B. Plasma homocysteine in the acute and convalescent phase after stroke. Stroke. 26:1995;795-800.
8. Hultberg B., Berglund M., Andersson A., Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res. 17:1993;687-689.
9. Nygard O., Vollset S.E., Refsum H.et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine study. JAMA. 274:1995;1526-1533.
10. Andersson A., Isaksson A., Hultberg B. Homocysteine export from erythrocytes and its implication for plasma sampling. Clin Chem. 38:1992;1311-1315.
11. Dudman N.P.B., Fu W., Yang K., Silberberg J.S., Crooks R. Homocysteine production in chronic renal failure. Neth J Med. 52:1998;22-23. (suppl).
12. Dudman N.P.B., Temple S.E., Guo X.W., Fu W., Perry M.A. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and in rats in vivo. Circ Res. 84:1999;409-416.
13. Guo X.W., Dudman N.P.B. Homocysteine alters interactions between human leukocyte and vascular endothelial cells in vitro. Neth J Med. 52:1998;58. (suppl).
14. Durand P., Lussier-Casan S., Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J. 11:1997;1-12.
15. Jacobsen D.W., Poddar R. Pathogenesis of hyperhomocysteinemia: vascular dysfunction at the cellular level. Neth J Med. 52:1998;1. (suppl).
16. Wang H., Sibinga N.E.S., Yoshizumi M., Perrella M.A., Haber E., Lee M.E. Inhibition of vascular endothelial cell growth by homocysteine: molecular mechanisms. Neth J Med. 52:1998;8-9. (suppl).
17. Kang S.-S., Wong P.W.K., Malinow M.R. Hyperhomocysteinemia as a risk factor for occlusive vascular disease. Annu Rev Nutr. 12:1992;279-289.
18. Dudman N.P.B., Hale S.E.T. Endothelial and leukocyte mediated mechanisms in homocysteine associated occlusive vascular disease. Rosenberg I.H., Graham I., Ueland P.M., Refsum H. Homocysteine metabolism: from basic science to clinical medicine. 1997;267-271 Kluwer Academic Publishers, Amsterdam.
19. Reichenbach D., Cowan M.J. Healing of myocardial infarction with and without reperfusion. Virmani R., Atkinson J.B., Fenoglio J.J. Cardiovascular pathology. 1991;61-85 WB Saunders, Philadelphia.
20. Wang P.Y., Kao C.H., Mui M.Y., Wang S.J. Leukocyte infiltration in acute hemispheric ischemic stroke. Stroke. 24:1993;236-240.
21. Lai K.N., Shute J.K., Lindley I.J.et al. Neutrophil attractant protein-1 interleukin 8 and its autoantibodies in IgA nephropathy. Clin Immunol Immunopathol. 80:1996;47-54.
22. Wilcken D.E.L., Dudman N.P.B. Homocystinuria and atherosclerosis. Lusis A.J., Rotter J.I., Sparkes R.S. Molecular genetics of coronary artery disease - candidate genes and processes in atherosclerosis. 1992;311-324 S Karger AG, Basel.
23. Reddy G.S.R., Wilcken D.E.L. Experimental homocystinuria in pigs: comparison with studies in sixteen homocystinuric patients. Metabolism. 31:1982;778-783.
24. Dudman N.P., Wilcken D.E., Stocker R. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia: relevance to development of arteriosclerosis. Arterioscler Thromb. 13:1993;512-516.
25. Blom H.J., Engelen D.P., Boers G.H.et al. Lipid peroxidation in hyperhomocysteinemia. J Inherit Metab Dis. 15:1992;419-422.
26. Ueland P.M., Refsum H., Stabler S.P., Malinow M.R., Andersson A., Allen R.H. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem. 39:1993;1764-1779.
27. Dudman N.P., Wilcken D.E., Wang J., Lunch J.F., Macey D., Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease: its occurrence, cofactor therapy, and enzymology. Arterioscler Thomb. 13:1993;1253-1260.